The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank.
Saved in:
| Title: | The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank. |
|---|---|
| Authors: | Lonie JM; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Brosda S; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Bonazzi VF; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Aoude LG; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Patel K; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia., Brown I; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Envoi Specialist Pathologists, Brisbane, QLD, Australia.; Department of Pathology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Sharma S; Medlab Pathology, Sydney, NSW, Australia.; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Lampe G; Department of Anatomical Pathology, Central Laboratory Pathology Queensland, Brisbane, QLD, Australia., Addala V; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Koufariotis LT; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Wood S; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Waddell N; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Dolcetti R; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Translational and Clinical Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia., Barbour AP; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.; Department of Surgery, Princess Alexandra Hospital, Brisbane, QLD, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Oct 12; Vol. 14, pp. 1220129. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37965317 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lonie+JM%22">Lonie JM</searchLink>; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Brosda+S%22">Brosda S</searchLink>; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Bonazzi+VF%22">Bonazzi VF</searchLink>; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Aoude+LG%22">Aoude LG</searchLink>; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Patel+K%22">Patel K</searchLink>; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Brown+I%22">Brown I</searchLink>; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Envoi Specialist Pathologists, Brisbane, QLD, Australia.; Department of Pathology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Sharma+S%22">Sharma S</searchLink>; Medlab Pathology, Sydney, NSW, Australia.; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Lampe+G%22">Lampe G</searchLink>; Department of Anatomical Pathology, Central Laboratory Pathology Queensland, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Addala+V%22">Addala V</searchLink>; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Koufariotis+LT%22">Koufariotis LT</searchLink>; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Wood+S%22">Wood S</searchLink>; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Waddell+N%22">Waddell N</searchLink>; Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Dolcetti+R%22">Dolcetti R</searchLink>; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Translational and Clinical Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Barbour+AP%22">Barbour AP</searchLink>; Surgical Oncology Group, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.; Department of Surgery, Princess Alexandra Hospital, Brisbane, QLD, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Oct 12; Vol. 14, pp. 1220129. <i>Date of Electronic Publication: </i>2023 Oct 12 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37965317 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2023.1220129 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1220129 Titles: – TitleFull: The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lonie JM – PersonEntity: Name: NameFull: Brosda S – PersonEntity: Name: NameFull: Bonazzi VF – PersonEntity: Name: NameFull: Aoude LG – PersonEntity: Name: NameFull: Patel K – PersonEntity: Name: NameFull: Brown I – PersonEntity: Name: NameFull: Sharma S – PersonEntity: Name: NameFull: Lampe G – PersonEntity: Name: NameFull: Addala V – PersonEntity: Name: NameFull: Koufariotis LT – PersonEntity: Name: NameFull: Wood S – PersonEntity: Name: NameFull: Waddell N – PersonEntity: Name: NameFull: Dolcetti R – PersonEntity: Name: NameFull: Barbour AP IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 10 Text: 2023 Oct 12 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
